Stocks · News reference

Intelligent Bio Solutions shares are trading lower after the company reported a wider FY26 net loss reflecting higher expenses.

Aug 19, 2026, 4:38 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARSep 2, 2026, 9:00 PMSEC EDGAR
8-K filing — INTELLIGENT BIO SOLUTIONS INC. (INBS)
Filed: 2026-09-02 AccNo: 0001493152-26-041253 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
INBS
BenzingaSep 1, 2026, 12:38 PMBenzinga Newsdesk
UPDATE: Intelligent Bio Solutions Commences ~$5M Placement Of Common Shares, Warrants At Combined Price Of $2.455 Per Share
Intelligent Bio Solutions Inc. ("INBS" or the "Company") (NASDAQ:INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has entered
INBS
BenzingaSep 1, 2026, 12:35 PMBenzinga Newsdesk
Intelligent Bio Solutions Reports 98.2% Accuracy In Codeine Study, Accelerates FDA 510(k) Submission To September 2026
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the results of its
INBS
BenzingaSep 1, 2026, 12:35 PMBenzinga Newsdesk
Intelligent Bio Solutions Commences ~$M Placement Of Common Shares, Warrants At Combined Price Of $2.455 Per Share
Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has entered
INBS